Table 3.
Clinical Characteristics of Participants in the qRT-PCR Cohort
| Characteristics | PCa Patients | BPH Patients | Healthy Controls |
|---|---|---|---|
| Total number | 47 | 29 | 25 |
| Age(years), median (IQR) | 69.00 (65.00–72.00) | 68.50 (61.25–72.00) | 68.50 (61.25–71.00) |
| PSA(ng/mL),median (IQR) | 16.91 (7.42–48.76) | 2.77 (1.35–6.97) | 0.93 (0.64–1.68) |
| Gleason score | |||
| ≤6 | 6 | ||
| 7 | 19 | ||
| ≥8 | 22 | ||
| Clinical stage | |||
| ≤T2 | 26 | ||
| >T2 | 21 | ||
| Metastasis | |||
| No | 32 | ||
| Yes | 15 |